Responses
Regular and Young Investigator Award Abstracts
Clinical Trial Completed
610 ImmunoRad: a stratified phase II trial of image guided hypofractionated radiotherapy with concurrent nelfinavir & PD-1 inhibition in advanced melanoma, lung cancer & renal cell carcinoma
Compose a Response to This Article
Other responses
No responses have been published for this article.
